Be Part of Progress in Eczema Research
Published: November 21, 2025
The focus of this study is to evaluate the efficacy and safety of an investigational tablet for adults with moderate to severe atopic dermatitis (eczema) and how it helps with skin redness, itching and swelling. Participants will receive either the study drug or a placebo in tablet form to take for 12 weeks and be evaluated on an outpatient basis. The total duration of participation for each person is expected to be approximately 18 weeks, including a 2-week follow-up after the treatment is complete.
Qualified participants may receive:
- All study-related medication(s) at no charge
- Study-related examinations & screenings at no cost
- All indicated study-related lab work or procedures at no cost
- Compensation for study-related time and travel
Who may be a good candidate for this atopic dermatitis (eczema) study? You may consider applying to be a participant if you meet the following criteria for qualification:
- Be 18 years of age or older
- Chronic atopic dermatitis (eczema) that has been present for at least six months
- The eczema covers at least 10% of the body (about the size of ten palmprints)
- Doctors rate the eczema as moderate or more severe based on standard medical scoring tools
